Methoden vergelijken
Bekijk de geselecteerde methoden naast elkaar; rijen die verschillen zijn gemarkeerd.
| Cost-Effectiveness Analysis for Policy× | Kosten-effectiviteitsanalyse in HTA× | |
|---|---|---|
| Vakgebied≠ | Public Policy | Zorgmanagement |
| Familie | Process / pipeline | Process / pipeline |
| Jaar van ontstaan≠ | 2015 | 1996 |
| Grondlegger≠ | Health-economics and program-evaluation tradition (Drummond et al.; Gold et al.) | Diane Meade Drummond, Michael Gold |
| Type≠ | Economic evaluation comparing cost per unit of effect | Economic evaluation methodology |
| Oorspronkelijke bron≠ | Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford: Oxford University Press. ISBN: 9780199665877 | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 |
| Aliassen≠ | Policy Cost-Effectiveness Analysis, CEA for Policy, Cost-Utility Analysis in Policy | CEA, Cost-Effectiveness Analysis Healthcare |
| Verwant≠ | 4 | 5 |
| Samenvatting≠ | Cost-effectiveness analysis (CEA) is an economic evaluation that compares competing policies or programs by their cost relative to a single, common measure of effect — lives saved, cases averted, years of education gained, or quality-adjusted life years (QALYs). Rather than valuing outcomes in money, CEA expresses results as an incremental cost-effectiveness ratio (ICER): the extra cost of one option per extra unit of outcome it delivers compared with the next-best alternative. Codified in standard references such as Drummond and colleagues' Methods for the Economic Evaluation of Health Care Programmes and the US Panel's Cost-Effectiveness in Health and Medicine, CEA is the dominant appraisal tool for health and increasingly for other public programs with a shared outcome metric. | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. |
| ScholarGateGegevensset ↗ |
|
|